4700+ Pharmaceutical Suppliers in the US | US Exporters Database

Explore the list of 4700+ Pharmaceutical Suppliers in the US with the US Exporters Database. The top Pharmaceutical suppliers in the US include Pfizer Inc. ($32 billion), Merck & Co. Inc. ($20 billion), Johnson & Johnson ($9 billion), and AbbVie Inc. ($8.5 billion), all with over 1.3 million units of pharmaceutical exports in 2023.

4700+ Pharmaceutical Suppliers in the US | US Exporters Database

Pharmaceutical suppliers play a crucial role in the healthcare industry by providing essential medications and medical products to hospitals, pharmacies, and healthcare facilities. These suppliers offer a wide range of pharmaceutical products, from prescription medications to over-the-counter medications and medical devices. The US pharmaceutical exports accounted for $90.30 billion in 2023, an increase of 8% from the previous year. In the first six months of 2024, the US exported pharmaceutical products worth $48.18 billion. 

  • Based on the US pharmaceutical Suppliers data, Pfizer Inc., Merck & Co. Inc., Johnson & Johnson, and AbbVie Inc. are the biggest pharmaceutical suppliers in the US. 

  • According to the US export data and US exporters data, there are 4700+ active pharmaceutical suppliers in the US exporting to 4100+ pharmaceutical buyers worldwide. 

  • Based on the US shipment data for 2023, there are a total of 264,000+ active pharmaceutical export shipments from the USA. 

  • The US exports and supplies pharmaceuticals to 115+ countries around the world. 

  • In global trade, the two-digit HS code for pharmaceutical products is 30.

In this article, we will explore the top pharmaceutical suppliers in the US and their impact on the healthcare industry. 

List of Top Pharmaceutical Suppliers in the US as per US Pharmaceutical Suppliers Data

US Supplier Company

Export Revenue in 2023 ($)

Exported Quantity (units)

1. Pfizer Inc.

$32 billion

1.8 million units

2. Merck & Co., Inc.

$20 billion

1.5 million units

3. Johnson & Johnson

$9 billion

1.6 million units

4. AbbVie Inc.

$8.5 billion

1.3 million units

5. Bristol-Myers Squibb

$8 billion

1.2 million units

6. Eli Lilly and Company

$7.5 billion

1.1 million units

7. Gilead Sciences, Inc

$7 billion

1 million units

8. Amgen Inc.

$6 billion

900 thousand units

9. Moderna, Inc.

$5.5 billion

800 thousand units

10. Biogen Inc.

$5 billion

750 thousand units

 

These are the leading top 10 pharmaceutical suppliers and exporters in the US, according to the US trade records and US suppliers list.

1. Pfizer Inc.: $32 billion

Pfizer Inc

  • A global biopharmaceutical company, known for vaccines and innovative therapies.

  • Total export quantity: 1.8 million units

  • Active export shipments: 2,500+

  • Headquarters: New York, NY

2. Merck & Co., Inc.: $20 billion

Merck & Co

  • It specializes in pharmaceutical therapies, vaccines, and oncology.

  • Total export quantity: 1.5 million units

  • Active export shipments: 2,300+

  • Headquarters: Rahway, NJ

3. Johnson & Johnson: $9 billion

Johnson & Johnson

  • One of the biggest providers of pharmaceutical products and consumer health products.

  • Total export quantity: 1.6 million units

  • Active export shipments: 2,200+

  • Headquarters: New Brunswick, NJ

4. AbbVie Inc.: $8.5 billion

AbbVie Inc

  • Known for specialty pharmaceuticals, particularly in immunology and oncology.

  • Total export quantity: 1.3 million units

  • Active export shipments: 1,800+

  • Headquarters: North Chicago, IL

5. Bristol-Myers Squibb: $8 billion

Bristol-Myers Squibb

  • Focuses on immunology and oncology, medication development, and production.

  • Total export quantity: 1.2 million units

  • Active export shipments: 1,700+

  • Headquarters: New York, NY

6. Eli Lilly and Company: $7.5 billion

Eli Lilly and Company

  • This company is a pioneer in biopharmaceuticals, particularly in diabetes and oncology.

  • Total export quantity: 1.1 million units

  • Active export shipments: 1,600+

  • Headquarters: Indianapolis, IN

7. Gilead Sciences, Inc.: $7 billion

Gilead Sciences

  • It specializes in antiviral therapies, especially for HIV and hepatitis.

  • Total export quantity: 1 million units

  • Active export shipments: 1,400+

  • Headquarters: Foster City, CA

8. Amgen Inc.: $6 billion

Amgen Inc

  • Leading biotechnology company focused on therapies for serious illnesses.

  • Total export quantity: 900,000 units

  • Active export shipments: 1,200+

  • Headquarters: Thousand Oaks, CA

9. Moderna, Inc.: $5.5 billion

Moderna, Inc

  • Known for mRNA-based vaccines and therapeutics, especially COVID-19.

  • Total export quantity: 800,000 units

  • Active export shipments: 1,000+

  • Headquarters: Cambridge, MA

10. Biogen Inc.: $5 billion

Biogen Inc

  • Focused on neuroscience, particularly in treatments for neurological disorders.

  • Total export quantity: 750,000 units

  • Active export shipments: 950+

  • Headquarters: Cambridge, MA

The Importance of Pharmaceutical Suppliers

Pharmaceutical suppliers are essential partners in the healthcare ecosystem, ensuring that healthcare providers have access to the medications and medical products they need to treat patients effectively. These suppliers work closely with pharmaceutical manufacturers to distribute medications to hospitals, pharmacies, and other healthcare facilities. Without pharmaceutical suppliers, healthcare providers would struggle to source the medications and medical products needed to care for patients.

US Pharmaceutical Export Data by Country

According to the US exporters data for 2023, the US exports the most pharmaceuticals to China ($9.89 billion), followed by the Netherlands and Belgium. The top 10 pharmaceutical export markets for the US in 2023 include:

1. China: $9.89 billion

2. Netherlands: $8.60 billion

3. Belgium: $8.06 billion

4. Germany: $6.55 billion

5. Japan: $6.32 billion

6. Canada: $5.86 billion

7. Spain: $5.52 billion

8. United Kingdom: $5.50 billion

9. Ireland: $4.02 billion

10. Switzerland: $2.76 billion

Top US Pharmaceutical Exports | US Export Data by HS Code

Based on the US Pharmaceutical export data by HS Code and product, the top pharmaceutical export varieties by the US in 2023 include:  

  • Human blood and animal blood (HS code 3002): $49.88 billion

  • Medicaments consisting of mixed products (HS code 3004): $34.48 billion

  • Pharmaceutical preparations (HS code 3006): $2.45 billion

  • Medicaments made of two or more constituents (HS code 3003): $1.52 billion

  • Wadding, gauze, and bandages (HS code 3005): $1.20 billion

  • Dried glands and other organs (HS code 3001): $746.55 million

US Pharmaceuticals Export Data for the Last 10 Years

Year of Exports

US Pharmaceutical Export Value ($)

2013

$39.70 billion

2014

$43.99 billion

2015

$47.09 billion

2016

$46.82 billion

2017

$44.93 billion

2018

$48.42 billion

2019

$53.15 billion

2020

$53.74 billion

2021

$77.84 billion

2022

$83.49 billion

2023

$90.30 billion

 

Find 4700+ Active Pharmaceutical Suppliers in the USA

If you are seeking to explore opportunities within the pharmaceutical industry in the United States, USImportdata can be a valuable resource. With USImportdata, you can easily access information on over 4700+ active pharmaceutical suppliers in the USA. This extensive database allows you to analyze trends, identify potential partners, and stay informed about the latest developments in the pharmaceutical sector. Any business or trader who is looking for the most reliable and authentic source of getting US pharmaceutical Suppliers data and reports on US trade data can contact us at info@tradeimex.in

Conclusion

We conclude that, with over 4700 pharmaceutical suppliers in the US, healthcare providers have a vast array of options when sourcing medications and medical products. By choosing a reliable and reputable supplier, healthcare organizations can ensure they have access to the medications they need to deliver high-quality care to patients. After understanding the importance of these suppliers and the factors to consider when choosing one, healthcare providers can make informed decisions and build successful partnerships within the pharmaceutical supply chain in the USA.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow